AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| WMK | Ann: Daily share buy-back notice - Appendix 3E | 24/04/18 | 0 | 29 | |||
|
|||||||
| WMK | Ann: Daily share buy-back notice - Appendix 3E | 20/04/18 | 0 | 54 | |||
|
|||||||
| WMK | Ann: Shareholder Update - May 2018 | 19/04/18 | 0 | 66 | |||
|
|||||||
| WMK | Ann: Daily share buy-back notice - Appendix 3E | 19/04/18 | 0 | 44 | |||
|
|||||||
| WMK | Ann: Daily share buy-back notice - Appendix 3E | 18/04/18 | 0 | 39 | |||
|
|||||||
| WMK | Ann: Daily share buy-back notice - Appendix 3E | 17/04/18 | 0 | 46 | |||
|
|||||||
| WMK | Ann: Daily share buy-back notice - Appendix 3E | 16/04/18 | 0 | 44 | |||
|
|||||||
| WMK | Ann: Net Tangible Asset Backing | 13/04/18 | 0 | 66 | |||
|
|||||||
See All Discussions
ASX News